4
Changes in Ownership
Wave Life Sciences, Inc. Filed Acc 0000950170-24-114422
Chief Financial Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Moran Kyle · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-10-11 | Exercise or conversion : show line 1 in the form | +25,000 | $2.48 | $62,000 | 44,777 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-11 | Exercise or conversion : show line 2 in the form Share Option (right to buy) | −25,000 | 0 | D |
Loading xslF345X05/ownership.xml…